Page last updated: 2024-10-31

mirtazapine and Fibrosis

mirtazapine has been researched along with Fibrosis in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdelhady, R1
Cavalu, S1
Saber, S1
Elmowafy, R1
Morsy, NE1
Ibrahim, S1
Abdeldaiem, MSI1
Samy, M1
Abd-Eldayem, MA1
Shata, A1
Elgharabawy, RM1
Akalay, A1
Ost, M1
Hanson, B1

Other Studies

2 other studies available for mirtazapine and Fibrosis

ArticleYear
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 161

    Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bleomycin; Fibrosis; Idiop

2023
[Mediastinal fibrosis and mirtazapin].
    La Revue de medecine interne, 2011, Volume: 32, Issue:7

    Topics: Antidepressive Agents, Tricyclic; Female; Fibrosis; Humans; Mediastinum; Mianserin; Middle Aged; Mir

2011